Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Cancer of the Esophagogastric Junction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06266299
What this trial is testing

KK2269 in Adult Participants With Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more
Kyowa Kirin Co., Ltd. 101
Early research (Phase 1)Not Yet RecruitingNCT07358884
What this trial is testing

First in Human Study of QLS5316 in Solid Tumors

Who this might be right for
Solid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more
Qilu Pharmaceutical Co., Ltd. 300
Not applicableLooking for participantsNCT06902545
What this trial is testing

Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Korea, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00130936
What this trial is testing

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Who this might be right for
Gastric CancerEsophageal CancerTumors
AHS Cancer Control Alberta 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07818070
What this trial is testing

A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma

Who this might be right for
Gastric CancerEsophagogastric Junction CancerEsophageal Adenocarcinoma
Ono Pharmaceutical Co., Ltd. 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06374901
What this trial is testing

Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.

Who this might be right for
Gastric Cancer
Xiangdong Cheng 134
Early research (Phase 1)Study completedNCT01183559
What this trial is testing

A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery

Who this might be right for
Cancer of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionCancer of the Stomach
Fox Chase Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00022139
What this trial is testing

Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 56
Testing effectiveness (Phase 2)Study completedNCT02730546
What this trial is testing

Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery

Who this might be right for
Gastric Cardia AdenocarcinomaGastroesophageal Junction AdenocarcinomaStage IB Gastric Cancer AJCC v7+5 more
Mayo Clinic 31
Testing effectiveness (Phase 2)WithdrawnNCT05678205
What this trial is testing

A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

Who this might be right for
Breast CancerGastric CancerGastroesophageal Junction Adenocarcinoma
Artiva Biotherapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT01472029
What this trial is testing

Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach
AIO-Studien-gGmbH 53
Testing effectiveness (Phase 2)Study completedNCT01630083
What this trial is testing

Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of EsophagusCLDN18.2-positive Gastric Adenocarcinoma
Astellas Pharma Global Development, Inc. 252
Testing effectiveness (Phase 2)UnknownNCT04792515
What this trial is testing

Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer

Who this might be right for
Locally Advanced Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University 67
Testing effectiveness (Phase 2)Study completedNCT00006081
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
M.D. Anderson Cancer Center 37
Early research (Phase 1)Study completedNCT01561014
What this trial is testing

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach+5 more
Wake Forest University Health Sciences 9
Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176
Early research (Phase 1)WithdrawnNCT06341647
What this trial is testing

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Who this might be right for
Breast CancerGastric CancerGastroesophageal Junction Adenocarcinoma
GC Cell Corporation
Testing effectiveness (Phase 2)Study completedNCT00062374
What this trial is testing

Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction

Who this might be right for
Gastric AdenocarcinomaStage II Gastric CancerStage III Gastric Cancer+1 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Ended earlyNCT01307956
What this trial is testing

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal AdenocarcinomaStage IIA Esophageal Cancer+1 more
University of Nebraska 11
Early research (Phase 1)Study completedNCT04772989
What this trial is testing

Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Who this might be right for
Advanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more
Arcus Biosciences, Inc. 94
Next Page
377